Well, well … It would seem that we have ended the option/rsu/psu grant phase and the last (?) round of financing phase before completion of Trial in 6 to 9 months.
I agree that the terms of the last financing was about the best we could hope for in terms of minimizing the amount of further dilution.
What happens in the next phase ? While if 2016 is any indication - it's when the market begins to anticipate a successful completion of the Trial. I call it the run up to results phase. It's the reason that the ability to buy shares at 40 cents ( and slightly below that ) just two months ago was a gift !
Those newbies that may be drawn in and that start to kick the tires will reference Paradigms math and equally do some math using Spectral's EBITDA blue sky estimates on 2025 and beyond (projected sales and profits).
Holders would be well advised to review EBITDA multiples for US based medical technology and device companies
All good !!
The next 6 months or so should be fun !
MM